Abivax SA American Depositary Shares (ABVX) — Cash Flow-to-Debt Ratio
Abivax SA American Depositary Shares (ABVX) has a Cash Flow-to-Debt Ratio of -0.43x as of March 2026, meaning its operating cash flow of $-50.52 Million could theoretically repay 0% of its total liabilities ($117.55 Million) in one year. Explore ABVX long-term investment intensity to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Abivax SA American Depositary Shares Cash Flow-to-Debt Ratio (2014–2025)
Historical debt coverage capacity for Abivax SA American Depositary Shares across 12 annual periods. Also explore ABVX asset base for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Abivax SA American Depositary Shares (2014–2025)
Year-by-year debt coverage analysis for Abivax SA American Depositary Shares. For market capitalisation and broader financial context, see Abivax SA American Depositary Shares market cap and net worth.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.21x | $-155.69 Million | $129.08 Million | ▼ -28.9% |
| 2024 | -0.94x | $-154.07 Million | $164.64 Million | ▼ -22.6% |
| 2023 | -0.76x | $-100.01 Million | $131.05 Million | ▲ +3.3% |
| 2022 | -0.79x | $-53.94 Million | $68.36 Million | ▼ -44.0% |
| 2021 | -0.55x | $-45.66 Million | $83.30 Million | ▲ +1.9% |
| 2020 | -0.56x | $-29.82 Million | $53.40 Million | ▲ +32.6% |
| 2019 | -0.83x | $-27.47 Million | $33.14 Million | ▼ -10.1% |
| 2018 | -0.75x | $-14.60 Million | $19.39 Million | ▲ +49.8% |
| 2017 | -1.50x | $-8.45 Million | $5.63 Million | ▲ +62.7% |
| 2016 | -4.02x | $-15.61 Million | $3.88 Million | ▼ -21.5% |
| 2015 | -3.31x | $-14.90 Million | $4.50 Million | ▼ -304.0% |
| 2014 | -0.82x | $-3.31 Million | $4.03 Million | — |